Literature DB >> 1514169

Diurnal rhythm in anticoagulant effect of heparin during a low dose constant rate infusion. A study in healthy volunteers.

J W Krulder1, A de Boer, A M van den Besselaar, A F Cohen, H C Schoemaker, E Briët, A E Meinders.   

Abstract

The objective of the study was to investigate possible diurnal rhythms in coagulation tests during a continuous intravenous infusion of unfractionated heparin. Six volunteers participated in the study, which was divided in a treatment (500 U heparin/h for 30 h) and a control experiment. Under basal conditions, no rhythm was found in coagulation tests. During heparin treatment, APTT, thrombin clotting time and anti-Xa activity showed a greater anticoagulant effect at night, with a striking decrease in the morning. In a search for the explanation of this phenomenon we looked for diurnal variations in the urinary excretion of heparin, in the plasma concentrations of antithrombin III and platelet factor 4, and in the effect of heparin added to the plasma samples in vitro. None of these studies provided the explanation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514169

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Impact of Protocolized Pharmacist Intervention on Critical Activated Partial Thromboplastin Time Values With Heparin Infusions.

Authors:  Rachelle Barry; Craig A Stevens; Trina Huynh; Dmitri Lerner
Journal:  J Pharm Technol       Date:  2021-07-14

2.  Edoxaban Dosing Time Affects Blood Coagulation Inhibition in Rats.

Authors:  Naoto Nagata; Muneo Kawasumi; Akio Fujimura; Hitoshi Ando
Journal:  TH Open       Date:  2021-04-14

3.  Evaluation of Anti-Activated Factor X Activity and Activated Partial Thromboplastin Time Relations and Their Association with Bleeding and Thrombosis during Veno-Arterial ECMO Support: A Retrospective Study.

Authors:  Mouhamed Djahoum Moussa; Jérôme Soquet; Antoine Lamer; Julien Labreuche; Guillaume Gantois; Annabelle Dupont; Osama Abou-Arab; Natacha Rousse; Vincent Liu; Caroline Brandt; Valentin Foulon; Guillaume Leroy; Guillaume Schurtz; Emmanuel Jeanpierre; Alain Duhamel; Sophie Susen; André Vincentelli; Emmanuel Robin
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.